As for inflammatory mediators, we observed higher serum levels of TNF‐alpha in PBC and NAFLD patients compared with CTRLs, but no differences in IL1‐beta, IL‐6 or IFN‐gamma. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.